Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the filing of a registration statement for an initial public offering of its American Depository Shares on the Nasdaq Global Market, under the ticker symbol ‘TLX’. Details such as the number of shares and pricing are yet to be determined, with the offering’s completion subject to market conditions. The offering will be supported by notable financial institutions, including Jefferies and Morgan Stanley, serving as joint book-running managers.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.